General Information of the Compound
| Compound ID |
CP0196916
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
4-[8-amino-3-[(1R,3S)-3-(5-oxo-4H-1,2,4-oxadiazol-3-yl)cyclohexyl]imidazo[1,5-a]pyrazin-1-yl]-N-[4-(trifluoromethyl)pyridin-2-yl]benzamide
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C27H23F3N8O3
|
||||||||||||||||||
| Molecular Weight |
564.528
|
||||||||||||||||||
| Canonical SMILES |
Nc1nccn2c(nc(-c3ccc(cc3)C(=O)Nc3cc(ccn3)C(F)(F)F)c12)[C@@H]1CCC[C@@H](C1)c1noc(=O)[nH]1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C27H23F3N8O3/c28-27(29,30)18-8-9-32-19(13-18)34-25(39)15-6-4-14(5-7-15)20-21-22(31)33-10-11-38(21)24(35-20)17-3-1-2-16(12-17)23-36-26(40)41-37-23/h4-11,13,16-17H,1-3,12H2,(H2,31,33)(H,32,34,39)(H,36,37,40)/t16-,17+/m0/s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
AZKCDBIMIYDADE-DLBZAZTESA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound